FDA Clearance Tracker · P810006-S022
COLLASTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTS
Last checked: Nov 20, 2026Latest source record: Sep 20, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Sep 20, 2006
Approved
Time to decision
355 days
Received Sep 30, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P810006-S022
- Device name
- COLLASTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTS
- Applicant
- Integra LifeSciences Corporation
- Applicant location
- Planisboro, NJ
- Received
- Sep 30, 2005
- Decided
- Sep 20, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P810006
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT INTEGRA NEUROSCIENCES PR, INC., ANASCO, PUERTO RICO FOR PACKAGING AND STERI-TECH, INC., SALINAS, PUERTO RICO FOR STERILIZATION.
Source documents
Other decisions for Integra LifeSciences Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251162 · Decided Oct 8, 2025 · 176 days after receipt
Device type: Instrument, Ultrasonic Surgical (LFL) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.